`
`SoloSTARO, a disposable injection pen for the injection of Lantus® and Apidra®
`for people with diabetes, has received the prestigious 2007 GOOD DESIGN
`Award, as awarded by The Chicago Athenaeum: Museum of Architecture and
`Design.
`
`Lantus® and Apidra® SoloSTAR®, created in cooperation with sanofi-aventis,
`considering the input of patients, nurses and doctors, is the result of four years of
`intensive development and the product of a rigorous, evidence-based, intelligent
`approach to design.
`
`The Lantus® and Apidra® SoloSTAR® device delivers leading performance in almost
`every respect. It has a lower dispense force and the largest selectable dose compared
`with the most broadly available pens in its class. The device is remarkably easy to use,
`has a discretely appealing form and is designed to facilitate extremely high volume
`manufacture and assembly.
`
`The elegant form of the SoloSTAR® device, together with its ease of use and advanced
`mechanical engineering has been designed and developed using design consultancy
`from DCA Design International Ltd.
`
`https://www.dca-design.com/latest/solostar-wins-2008-good-design-award
`
`AXE HBI"
`
`Depon0J/
`
`DaltWif Rpt/e
`
`WWW DEPOBOOKPRODUCTS COM
`
`Sanofi Exhibit 2223.001
`Mylan v. Sanofi
`IPR2018-01676
`
`
`
`The quality and the supply of Lantus® and Apidra® SoloSTAR® meet the high
`standards of the medical industry.
`
`The Lantus® and Apidra® SoloSTAR® device is being put into the permanent Design
`Collection of the Chicago Athenaeum: Museum of Architecture and Design.
`
`(Lantus® SoloStare and Apidra0 SoloStar() are registered brands of Sanofi Aventis).
`
`GOOD
`DESIGN
`
`Link to 'Medical and Scientific' in 'Sectors'
`Link to 'Pharmaceutical drug delivery' in 'Medical and Scientific'
`
`Share this page:
`
`RELATED NEWS
`
`DCA talks to Marketing Week about
`specifications and the creative process
`
`related work
`
`Sanofi - SoloSTAR®
`
`Sanofi - AllStarTM
`
`Sanofi - CIikSTAR®
`
`Sanofi - Lyxumia®
`
`https://www.dca-design.com/latest/solostar-wins-2008-good-design-award
`
`Sanofi Exhibit 2223.002
`Mylan v. Sanofi
`IPR2018-01676
`
`
Accessing this document will incur an additional charge of $.
After purchase, you can access this document again without charge.
Accept $ Charge
Still Working On It
This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.
Give it another minute or two to complete, and then try the refresh button.
A few More Minutes ... Still Working
It can take up to 5 minutes for us to download a document if the court servers are running slowly.
Thank you for your continued patience.
This document could not be displayed.
We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.
Your account does not support viewing this document.
You need a Paid Account to view this document. Click here to change your account type.
Your account does not support viewing this document.
Set your membership
status to view this document.
With a Docket Alarm membership, you'll
get a whole lot more, including:
- Up-to-date information for this case.
- Email alerts whenever there is an update.
- Full text search for other cases.
- Get email alerts whenever a new case matches your search.
One Moment Please
The filing “” is large (MB) and is being downloaded.
Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.
Your document is on its way!
If you do not receive the document in five minutes, contact support at support@docketalarm.com.
Sealed Document
We are unable to display this document, it may be under a court ordered seal.
If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.
Access Government Site
